FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines Government advisers say it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall The Independent UK · Jun 5, 2024
Stock Market Today: Stocks End Mixed on the Day, Higher on the Week The latest consumer sentiment data showed inflation concerns are on the rise. Kiplinger · May 10, 2024
Novavax strikes $1.2 billion deal with Sanofi in major turnaround It's a major turnaround for a drug company that warned last year about its ability to stay in business. Axios · May 10, 2024
French, US Drug Firms Team Up For Covid-flu Shot French pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines with a flu shot. International Business Times · May 10, 2024
Cheaper private Covid jabs may end up as costly as pricier ones, say experts Exclusive: Multi-dose vials could push up charge per patient, with experts warning cost could widen inequalities The Guardian - UK · Apr 2, 2024
Cost of private Covid jabs risks widening health inequalities, experts warn Concerns that some groups who are more at risk from virus face hefty price tag, as Boots set to charge almost £100 a shot The Guardian - UK · Mar 28, 2024
Pharmacies in England and Scotland to offer private Covid jabs – for £45 Pharmadoctor is offering appointments from 1 April for vaccinations and intends to add more pharmacies to its network The Guardian - UK · Feb 2, 2024
Novavax COVID-19 vaccine approved Vaccine uses different technology than Moderna and Pfizer's mRNA targeting strategy Salon · Oct 5, 2023
US adds another option for fall COVID vaccination with updated Novavax shots U.S. regulators have added another option for fall COVID-19 vaccination, updated shots made by Novavax The Independent UK · Oct 3, 2023
Oxford-Serum institute malaria vaccine recommended for use by WHO WHO recommends R21/Matrix-M malaria vaccine developed by Oxford and Serum Institute of India. Vaccine has met safety, quality and effectiveness standards. Serum Institute has established production capacity for 100 million doses/annum. Vaccine efficacy over 12 months is 75% at sites with high seasonal malaria transmission and 68% at sites with… The Hindu · Oct 2, 2023
When and where can you get the updated COVID booster? And who needs one? What you need to know, according to experts All Americans ages 6 months and older are eligible for the new jabs, the CDC said Tuesday. Fortune · Sep 13, 2023
CDC greenlights two updated COVID-19 vaccines, but how will they fare against the latest variants? 5 questions answered On Sept. 12, 2023, the Centers for Disease Control and Prevention recommended the newly formulated COVID-19 vaccines for all Americans ages 6 months and up, hours after its expert advisory committee voted 13 to 1 in favor of recommending the vaccines. The Conversation · Sep 13, 2023
CDC OKs updated COVID-19 vaccine, clearing way for shots to begin this week Chicago public health officials have said the CDC approval was all they needed to “begin the rollout” of the vaccine, which will be free for all city residents. “We already have the vaccine in Chicago,” Dr. Geraldine Luna, medical director for the Chicago Department of Public Health, said Monday. Chicago Sun-Times · Sep 13, 2023
CDC panel recommends updated COVID vaccines. Shots could be ready this week Americans may soon be able to get an updated COVID-19 vaccine The Independent UK · Sep 12, 2023
Roll Call · Sep 11, 2023 FDA greenlights new COVID-19 shots for this fall - Roll Call The FDA approved reformulated COVID-19 vaccines from Pfizer and Moderna, but deferred an expected authorization for Novavax’s vaccine.
Inverse · Aug 17, 2023 When Should You Get Your Next Covid-19 Booster? There’s One Easy Answer To This Question Vaccine manufacturers like Pfizer/BioNTech, Moderna, and Novavax are switching up their shots in preparation for the new season.
Tribune News Service · Jun 16, 2023 COVID boosters should be updated to target XBB strain, US health advisers say COVID-19 shots should be reformulated to target an XBB subvariant of the highly infectious omicron strain to provide the best protection during the U.S. fall and winter season, health regulators said.
The Week · Apr 17, 2023 Sanofi: the new protein-based Covid vaccine to be used in the UK The University of Edinburgh’s Neil Mabbott on the vaccine technology being used for Covid booster jabs from this month.
Wales Online · Apr 15, 2023 Everything we know about new Sanofi Covid vaccine now being used in UK The vaccine being used in the Spring booster campaign works in a different way to previous jabs
The Conversation · Apr 14, 2023 Sanofi vaccine: what to know about this protein-based COVID booster being offered in the UK In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to…
The Guardian - UK · Apr 7, 2023 Cancer and heart disease vaccines ‘ready by end of the decade’ Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives
Salon · Jan 31, 2023 Experts unsure about who needs boosters FDA expert committee needs more data to decide when to give out COVID boosters — and who needs them most
Tribune News Service · Jan 27, 2023 FDA experts are still puzzled over who should get which COVID-19 shots and when At a meeting to simplify the nation’s COVID-19 vaccination policy, the FDA’s panel of experts could agree on only one thing: Information is woefully lacking about how often different groups of Americans need to be vaccinated. That data gap has contributed to widespread skepticism, undervaccination, and ultimately unnecessary deaths from…
Reuters · Jan 26, 2023 FDA advisers back the same COVID vaccine for initial shots, boosters Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of targeting the same coronavirus strain for initial COVID-19 vaccine doses and boosters going forward, but some expressed skepticism about whether all Americans need to receive the shots annually.
Fortune · Jan 9, 2023 Vaccines are not making COVID strains like 'Kraken' stronger Scientists say there is no evidence to suggest that vaccinations are making COVID "stronger" and that mutations are a normal part of virus evolution.